Analyst Ratings for Treace Medical Concepts
Portfolio Pulse from Benzinga Insights
Analysts have provided ratings for Treace Medical Concepts (NASDAQ:TMCI) within the last quarter, with 2 bullish and 2 indifferent ratings. The average 12-month price target for TMCI is $27.38, a 10.73% decrease from the previous average price target of $30.67.
August 28, 2023 | 2:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Analysts have a mixed view on Treace Medical Concepts with 2 bullish and 2 indifferent ratings. The average 12-month price target is $27.38, indicating a potential downside.
The mixed analyst ratings indicate uncertainty about the company's future performance. The decrease in the average price target suggests that analysts expect the stock price to go down in the next 12 months.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100